Craig-Hallum Raises Celcuity Stock Price Target to $141 Following NDA Progress
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowCraig-Hallum increased its price target for Celcuity to $141 due to advancements in their New Drug Application (NDA). This change reflects the firm’s confidence in the company's developments. The updated target may impact investor sentiment and trading strategies in the biopharmaceutical sector. Celcuity's stock performance and market positioning could be positively influenced by this revision.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
